TT
TG Therapeutics Inc
🇩🇪XSTU.NKB2GermanyHealthcare
€45.80EURdown -0.40 (-0.87%)OpenEnd of day5:13 PM
Price€45.80-0.40 (-0.87%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US88322Q1085
- CUSIP
- Not reported
Company
- Employees
- 399
- Headquarters
- Morrisville, United States
- CEO
- Mr. Michael S. Weiss Esq., J.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- $2.81
- P/E LTM
- 19.57
- Div yield
- 0%
Fundamentals (LTM)
- Revenue
- $799.54M+76.08%up year on year
- Net income
- $441.49M+630.24%up year on year
- Gross margin
- 82.36%-5.28%down year on year
- Free cash flow
- -$560K+99.05%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.